Position in GERN
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$14,900
+$1,700 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#207
of 255 holders
Holding Since
Mar 2020
13 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Fort Sheridan Advisors LLC holds $2,120,562 across 5 Biotechnology names. GERN ranks #5 (0.7% of the industry book) .
All Filings in GERN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,900 | 10,000 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $13,200 | 10,000 | Shares | Sole | 2026-02-10 | |
| 2022-09-30 | $73,710 | 31,500 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $48,825 | 31,500 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $42,840 | 31,500 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $38,430 | 31,500 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $43,155 | 31,500 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $44,415 | 31,500 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $49,770 | 31,500 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $50,085 | 31,500 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $54,810 | 31,500 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $68,670 | 31,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $37,485 | 31,500 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||